Navigation Links
MichBio Announces Annual Business Meeting Keynote and Pre-Meeting Workshop
Date:3/17/2009

ANN ARBOR, Mich., March 17 /PRNewswire-USNewswire/ -- MichBio, the association for Michigan biosciences, will host Harry Stylli, Ph.D., president and CEO of San Diego, CA-based Sequenom, Inc. as the keynote speaker for its May 6 Annual Business Meeting at the Kensington Court Hotel in Ann Arbor. Sequenom has established a presence in Michigan with recent acquisitions of the Center for Molecular Medicine (CMM) in Grand Rapids and Ann Arbor-based Sensigen.

Dr. Harry Stylli has a track record of nearly two decades, demonstrating entrepreneurial leadership in the biotechnology and pharmaceutical industries, and has broad experience in successfully translating innovative technology into commercial opportunities. He was appointed president, CEO, and a board member of Sequenom, Inc. in 2005. Most recently, he served as president and CEO of Xencor, Inc., a privately held biotechnology company. Previously, Dr. Stylli was president and CEO of CovX Pharmaceuticals. Dr. Stylli co-founded Aurora Biosciences in 1995, and in 2001 he was key to the success of Aurora's acquisition by Vertex Pharmaceuticals. Following the merger, Dr. Stylli continued on with the company as president of Aurora Biosciences and Panvera. From 1987 to 1995, Dr. Stylli held various positions with GlaxoSmithKline. Dr. Stylli is a director of Molecular Insight Pharmaceuticals, Inc., and an advisor to Nanosyn. He has a B.S. degree from the University of East London, U.K., a Ph.D. from London University's Faculty of Medicine, and an M.B.A. from the U.K.'s Open University.

The MichBio Annual Business Meeting draws the industry's leaders and most influential bioscience professionals from across the state. It will be held at the Kensington Court Hotel in Ann Arbor, MI. Reception and networking begin at 5:00 p.m., followed by a dinner meeting at 6:30 p.m. and keynote address at 7:15 p.m. The cost before May 1 is $80 for members, $110 for non-members. After May 1
'/>"/>

SOURCE MichBio
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. MichBio Will Publish 2009 Michigan Biosciences Directory and Resource Guide
2. MichBio Expo Draws Nearly 500 Professionals; Career Day Raises Profile
3. MichBio Expo Will Feature Sessions for Michigan Manufacturers Interested in Entering Medical Device Market
4. Presenters Announced For MichBio Expos Emerging Business Showcase
5. Early-Bird Pricing Ends Soon for MichBio Expo Attendees and Exhibitors; Award Nominations Due Nov. 1
6. Start-Up and Emerging Biotech Companies Will Tell Their Stories at Biosciences Showcase Planned for MichBio Expo
7. Christine Poon Will Keynote MichBio Expo
8. MichBio Will Host Workshop on Capital Formation Prior to April 22 Annual Meeting
9. MichBio Announces Annual Meeting Keynote and Pre-Meeting Workshop
10. MichBio Responds to Governors Plan to Repeal Tort Reform Laws
11. MichBio Expo Opens in Lansing Next Week
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... /PRNewswire/ -- Capitalizing on the continued ... an active venture capital market, leaders from BioCrossroads, ... Fund, Indiana University, Purdue University, the University of ... Suisse today announced the establishment of the INext ... funds. ,, Organized through BioCrossroads, Indiana,s initiative to ...
(Date:12/16/2009)... culture supplement? InVitria has what scientists have been asking for! ... improves the growth and productivity of CHO cells. Developed for ... animal free, well defined and consistent recombinant CHO supplement. ... ... 16, 2009 -- Scientists working with CHO cells can now ...
(Date:12/15/2009)... (JBEI), one of three Department of Energy (DOE) bio-energy ... to protect its valuable intellectual property. , ... ... 15, 2009 -- Surety, LLC , the leading ... announced that the Joint BioEnergy Institute (JBEI), one of ...
(Date:12/15/2009)... Va., Dec. 15 AstraZeneca (NYSE: ... of Virginia (UVa) in Charlottesville, today announced ... research collaboration to enhance development of new ... with a secondary focus on peripheral vascular ... ) ,, The collaborative preclinical research projects ...
Breaking Biology Technology:Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 2Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 3Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 4Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 5Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 3Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 4Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 5AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 2AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 3
... 25 NuVasive, Inc. (Nasdaq:,NUVA), a medical device company ... the spine, announced today,details relating to its fourth quarter ... on Tuesday, February 19, 2008, after,the close of the ... Tuesday, February 19, 2008 at,5:30 p.m. ET / 2:30 ...
... Arena Pharmaceuticals,Inc. (Nasdaq: ARNA ) announced today that ... of a second generation oral niacin receptor agonist,under a ... of atherosclerosis and other disorders. The initiation of this,trial ... very pleased with the progress of this collaboration,investigating the ...
... 24 ,Exelixis, Inc. (Nasdaq: EXEL ) announced today ... of Exelixis, will present at,the 2008 Wachovia Healthcare Conference ... January 31, 2008., The presentation will be webcast ... Investors on the Exelixis website at, http://www.exelixis.com ., ...
Other Biology Technology:NuVasive Announces Webcast and Conference Call of Fourth Quarter and Full Year 2007 Results 2NuVasive Announces Webcast and Conference Call of Fourth Quarter and Full Year 2007 Results 3Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Second Generation Niacin Receptor Agonist Under Its Collaboration With Merck & Co., Inc. 2Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Second Generation Niacin Receptor Agonist Under Its Collaboration With Merck & Co., Inc. 3
(Date:12/15/2009)... Extinct woolly mammoths and ancient American horses may ... several thousand years longer than previously thought. After ... Alaska, a team of researchers used cutting-edge techniques ... in permafrost samples dated to between 7,600 and ... at least one population of these now-extinct mammals ...
(Date:12/15/2009)... and economic toll on society. It is estimated that ... in U.S. waters and it,s likely that rip currents account ... disconnect exists between rip current research and public understanding. ... and more importantly, most people do not know how to ... The goal of the Rip Current Symposium is to identify ...
(Date:12/14/2009)... AlaskaScientists have identified a novel antifreeze molecule in a ... 100 degrees Fahrenheit. Unlike all previously described biological antifreezes ... little or no protein. It is composed of a ... new places within the cells of organisms. , ... this molecule is a whole new kind of antifreeze ...
Breaking Biology News(10 mins):Late-surviving megafauna exposed by ancient DNA in frozen soil 2Late-surviving megafauna exposed by ancient DNA in frozen soil 3Late-surviving megafauna exposed by ancient DNA in frozen soil 4Scientists isolate new antifreeze molecule in Alaska beetle 2AIMS Benefit Solutions Offering Long Term Care Insurance Featuring CASH First 28TM 29 from United of Omaha 62932 1AIMS Benefit Solutions Offering Long Term Care Insurance Featuring CASH First 28TM 29 from United of Omaha 62932 2AIMS Benefit Solutions Offering Long Term Care Insurance Featuring CASH First 28TM 29 from United of Omaha 62932 3Your Online Resource For Plastic Surgery Information 62930 1Your Online Resource For Plastic Surgery Information 62930 2Statement of HDMA President and CEO John M Gray on the Importation of Prescription Drugs 62928 1Statement of HDMA President and CEO John M Gray on the Importation of Prescription Drugs 62928 2
... cells allow plants to build new organs throughout their ... and genetic factors work together to prevent plants from ... tumor-like. Scientists from the Max Planck Institute for Developmental ... growth-enhancing hormone and a regulatory protein, which controls the ...
... counterintuitive experiment has resulted in one of the longest ... new door for anti-aging research in humans. , Scientists ... of the SIR2 gene can promote longevity in yeast, ... widely and incorporated into anti-aging drug development programs at ...
... five New York flu seasons , On the eve of ... Research (TIGR) have captured influenza evolution in action. In a ... researchers report the first large-scale project to sequence the influenza ... evolving flu virus in a human population--and a new strategy ...
Other Biology News:Max Planck researchers make a breakthrough in plant stem cell research 2Max Planck researchers make a breakthrough in plant stem cell research 3New technique multiplies life span in simple organisms 2New technique multiplies life span in simple organisms 3First big influenza genome study reveals flu evolution 2First big influenza genome study reveals flu evolution 3First big influenza genome study reveals flu evolution 4
...
Cell Lysis Buffer is used to lyse cells under nondenaturing conditions....
... 200 IS System is ideal for developing ... reagents. This system contains the new, improved, ... Luminex. The user can design specific templates ... system has fully integrated graphing and data ...
... stably express the regulatory GeneSwitch protein ... functionally tested for induction ability by ... vector pGene/V5-His/lacZ and by assaying for ... (Figure 1). These cell lines should ...
Biology Products: